Stock Scorecard
Stock Summary for Natural Alternatives International Inc (NAII) - $6.30 as of 4/25/2024 6:31:44 AM EST
Total Score
14 out of 29
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for NAII
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for NAII
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for NAII
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for NAII
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for NAII
Financial Details for NAII
Company Overview |
|
---|---|
Ticker | NAII |
Company Name | Natural Alternatives International Inc |
Country | USA |
Description | Natural Alternatives International, Inc. is dedicated to formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. The company is headquartered in Carlsbad, California. |
Sector Name | LIFE SCIENCES |
Industry Name | MEDICINAL CHEMICALS & BOTANICAL PRODUCTS |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 5/13/2024 |
Stock Price History |
|
Last Day Price | 6.30 |
Last Day Price Updated | 4/25/2024 6:31:44 AM EST |
Last Day Volume | 6,598 |
Average Daily Volume | 5,254 |
52-Week High | 9.03 |
52-Week Low | 5.06 |
Last Price to 52 Week Low | 24.51% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 13.32 |
Sector PE | 61.73 |
5-Year Average PE | -0.58 |
Free Cash Flow Ratio | 2.31 |
Industry Free Cash Flow Ratio | 55.72 |
Sector Free Cash Flow Ratio | 30.74 |
Current Ratio Most Recent Quarter | 4.06 |
Total Cash Per Share | 2.73 |
Book Value Per Share Most Recent Quarter | 14.04 |
Price to Book Ratio | 0.48 |
Industry Price to Book Ratio | 2.22 |
Sector Price to Book Ratio | 22.08 |
Price to Sales Ratio Twelve Trailing Months | 0.32 |
Industry Price to Sales Ratio Twelve Trailing Months | 1.19 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.16 |
Share Statistics |
|
Total Shares Outstanding | 6,088,800 |
Market Capitalization | 38,359,440 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 2.41% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 74.10% |
Annual Earnings Growth | -76.46% |
Reported EPS 12 Trailing Months | -0.70 |
Reported EPS Past Year | -0.64 |
Reported EPS Prior Year | 0.43 |
Net Income Twelve Trailing Months | -4,109,000 |
Net Income Past Year | 2,522,000 |
Net Income Prior Year | 10,712,000 |
Quarterly Revenue Growth YOY | 26.50% |
5-Year Revenue Growth | 2.92% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 16,595,000 |
Total Cash Past Year | 13,604,000 |
Total Cash Prior Year | 21,833,000 |
Net Cash Position Most Recent Quarter | 7,224,000 |
Net Cash Position Past Year | 4,087,000 |
Long Term Debt Past Year | 9,517,000 |
Long Term Debt Prior Year | 9,795,000 |
Total Debt Most Recent Quarter | 9,371,000 |
Equity to Debt Ratio Past Year | 0.90 |
Equity to Debt Ratio Most Recent Quarter | 0.90 |
Total Stockholder Equity Past Year | 88,772,000 |
Total Stockholder Equity Prior Year | 88,520,000 |
Total Stockholder Equity Most Recent Quarter | 85,455,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | False |
Liquidity Rating | None |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.13 |
MACD Signal | 0.15 |
20-Day Bollinger Lower Band | 5.69 |
20-Day Bollinger Middle Band | 6.25 |
20-Day Bollinger Upper Band | 6.82 |
Beta | 0.56 |
RSI | 56.08 |
50-Day SMA | 6.56 |
200-Day SMA | 10.16 |
System |
|
Modified | 4/25/2024 6:31:45 AM EST |